High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9.
about
Paediatric acute myeloid leukaemia with the t(7;12)(q36;p13) rearrangement: a review of the biological and clinical management aspectsPediatric AML: From Biology to Clinical ManagementHuman eIF4AIII interacts with an eIF4G-like partner, NOM1, revealing an evolutionarily conserved function outside the exon junction complexThe antioxidant protein peroxiredoxin 4 is epigenetically down regulated in acute promyelocytic leukemiaEvaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemiaCytogenetics and outcome of infants with acute lymphoblastic leukemia and absence of MLL rearrangements.Nom1 mediates pancreas development by regulating ribosome biogenesis in zebrafish.Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia.A Novel Three-Colour Fluorescence in Situ Hybridization Approach for the Detection of t(7;12)(q36;p13) in Acute Myeloid Leukaemia Reveals New Cryptic Three Way Translocation t(7;12;16).Acute myeloid leukemia in infants: biology and treatmentMNX1 Is Oncogenically Upregulated in African-American Prostate Cancer.Homeobox protein HB9 binds to the prostaglandin E receptor 2 promoter and inhibits intracellular cAMP mobilization in leukemic cells.Comparative genomic analysis of the false killer whale (Pseudorca crassidens) LMBR1 locus.The dual role of HLXB9 in leukemia.Acute lymphoblastic leukemiaAcute myeloid leukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia
P2860
Q26775693-82532EB7-2058-430F-BC52-548518CD4F6BQ26799773-6FFA84AE-9756-466B-8C2D-049A94B14B0EQ27939806-35230041-57D8-4528-937E-3BE654990225Q33809163-305C066C-677F-44DA-A71D-31E6D46CF7D2Q34542996-AFE7EE98-D739-42C3-8DB9-1689F09DCDF3Q34845478-83234DB1-912D-48BF-B6DE-A104A8C5A179Q35195571-82463F6C-E867-412A-8347-6AEE6586CD0BQ36053792-69BE1469-F5A9-48C7-AF4B-9F0C9665CACEQ37061752-30793167-3FC7-4F69-B61D-C5C7012790EDQ38479156-AAFA402B-FFE2-4AAB-BBFF-E08F57DADFB3Q38734374-BB5448CC-0061-45ED-9225-AE89F671B6C0Q39263295-E2D30456-F104-41B7-8A0A-A4995BA9AAB7Q48062528-32DEB6D7-57E9-4009-AB1B-31AB86403103Q54402336-95EB9F08-62DD-4F52-A5C0-96D1CAC58B37Q58481759-A9A28D37-756F-454A-9E28-86818A45EEFEQ58481761-7AE1ADFB-E039-4EF3-BF20-172EAD6F79D3Q58481810-E2FAE69D-9A01-435F-B358-9290360FE6CDQ58481811-01279F52-777F-4B2E-A5EC-01412AF40441
P2860
High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
High incidence of t(7;12)(q36; ...... d ectopic expression of HLXB9.
@ast
High incidence of t(7;12)(q36; ...... d ectopic expression of HLXB9.
@en
High incidence of t(7;12)(q36; ...... d ectopic expression of HLXB9.
@nl
type
label
High incidence of t(7;12)(q36; ...... d ectopic expression of HLXB9.
@ast
High incidence of t(7;12)(q36; ...... d ectopic expression of HLXB9.
@en
High incidence of t(7;12)(q36; ...... d ectopic expression of HLXB9.
@nl
prefLabel
High incidence of t(7;12)(q36; ...... d ectopic expression of HLXB9.
@ast
High incidence of t(7;12)(q36; ...... d ectopic expression of HLXB9.
@en
High incidence of t(7;12)(q36; ...... d ectopic expression of HLXB9.
@nl
P2093
P356
P1476
High incidence of t(7;12)(q36; ...... d ectopic expression of HLXB9.
@en
P2093
Anne R M von Bergh
Elisabeth R van Wering
Ellen van Drunen
Gudmar Lönnerholm
H Berna Beverloo
Ina Hainmann
Jules P Meijerink
Laura J C M van Zutven
P304
P356
10.1002/GCC.20335
P50
P577
2006-08-01T00:00:00Z